Tabrecta: Side Effects & Dosing

Download App
FAQs
Thailand
search
Sign In

Tabrecta

Basic Prescribing Info

Contents

Capmatinib

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EP01 - capmatinib ; Belongs to the class of cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors. Used in the treatment of cancer.

Continue with Google

Already a member? Sign In